Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Mar 6, 2012

LaserGen Wins Grant for Next-Gen Sequencing Test for Wound Infection Pathogens

  • LaserGen won an SBIR grant from the U.S Army Medical Research and Material Command (USAMRMC) to support studies demonstrating the feasibility of the firm’s next-generation sequencing (NGS) platform to identify wound-infecting pathogens commonly found in combat. The ultimate aim is to develop a rapid, portable pathogen diagnostic system to enable optimum antibiotic use, without the need to resort to broad-spectrum drugs.

    LaserGen introduced its NGS system just last month. The platform is based on the firm’s pulsed multiline excitation (PME) detection technique, Lightning Terminators™ chemistry, and photocleavable cyclic reversible terminator technology.

    Details about the structure of its Lightning Terminators were published Angewandte Chemie in January. “This milestone illustrates not only the superior accuracy of the system, but also the lower cost it enabled by reducing informatics needs and validation efforts,” comments Michale Metzker, Ph.D., LaserGen CEO. “This field technology being developed for the U.S. army is only one of many potential applications of the LaserGen approach.”

Related content


GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

What Does Brexit Mean for Biotech?

Do you agree with the contention that Brexit will NOT have a long-term negative impact on the British biotech industry?

More »